BioCryst Pharmaceuticals
BCRX
#4604
Rank
โ‚ฌ2.09 B
Marketcap
8,24ย โ‚ฌ
Share price
-1.37%
Change (1 day)
12.53%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2026 (TTM): -โ‚ฌ0.4 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ0.88 Billion. In 2025 the company made an earning of โ‚ฌ0.23 Billion, an increase over its 2024 earnings that were of -โ‚ฌ76.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.4 Billion-268.48%
2025 โ‚ฌ0.23 B-407.51%
2024 -โ‚ฌ76.4 Million-61.56%
2023 -โ‚ฌ0.2 Billion-7.43%
2022 -โ‚ฌ0.22 Billion34.42%
2021 -โ‚ฌ0.16 Billion-0.55%
2020 -โ‚ฌ0.17 Billion67.88%
2019 -โ‚ฌ95.68 Million7.55%
2018 -โ‚ฌ88.97 Million53.92%
2017 -โ‚ฌ57.8 Million19.29%
2016 -โ‚ฌ48.45 Million28.19%
2015 -โ‚ฌ37.8 Million-4.8%
2014 -โ‚ฌ39.71 Million50.09%
2013 -โ‚ฌ26.46 Million-23.29%
2012 -โ‚ฌ34.49 Million-26.19%
2011 -โ‚ฌ46.73 Million54.78%
2010 -โ‚ฌ30.19 Million150.1%
2009 -โ‚ฌ12.07 Million-49.43%
2008 -โ‚ฌ23.87 Million14.07%
2007 -โ‚ฌ20.93 Million-49.31%
2006 -โ‚ฌ41.28 Million72.87%
2005 -โ‚ฌ23.88 Million22.08%
2004 -โ‚ฌ19.56 Million75.3%
2003 -โ‚ฌ11.16 Million-25.36%
2002 -โ‚ฌ14.95 Million225.05%
2001 -โ‚ฌ4.6 Million-56.6%
2000 -โ‚ฌ10.6 Million50.63%
1999 -โ‚ฌ7.04 Million38.05%
1998 -โ‚ฌ5.1 Million-52.46%
1997 -โ‚ฌ10.72 Million58.44%
1996 -โ‚ฌ6.77 Million-14.44%
1995 -โ‚ฌ7.91 Million28.57%
1994 -โ‚ฌ6.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚ฌ9.42 B-2,462.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ8.79 B-2,304.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚ฌ21.49 M-105.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚ฌ68.57 M-117.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚ฌ56.64 Million-85.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.28 Billion-31.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚ฌ7.11 Million-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚ฌ19.51 Million-95.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ51.92 M-113.01%๐Ÿ‡บ๐Ÿ‡ธ USA